Egypt's first Pfizer vaccines shipment arrived from the US in late September.
Egyptian Minister Hala Zayed stated Monday that Egypt is negotiating to domestically manufacture anti-COVID vaccine “Modern” at its factories at VACSERA.
Egypt’s Health Minister Hala Zayed said the country has received a total of 33.657 million doses of AstraZeneca, Sinovac, Sinopharm, Sputnik V and Johnson & Johnson vaccines.
A total of 13.4 million doses were administered to citizens so far.
These shipments of vaccines will be provided in travel vaccination centers, the ministry added.
The Ministry will receive the first shipment of 260,000 doses of Pfizer vaccine in the coming new period.
Six patients have died from the virus over the past 24 hours, raising the death toll to 16,588.
four patients have died from the virus over the past 24 hours, raising the death toll to 16,528.
Four patients have died from the virus over the past 24 hours, raising the death toll to 16,481.
Seven patients have died from the virus over the past 24 hours, raising the death toll to 16,477.
seven patients have died from the virus over the past 24 hours, raising the death toll to 16,403.
Shortly afterward, Egypt will receive other shipments of Johnson & Johnson COVID-19 Vaccine.
The analysis, carried out between April 5 and May 16, found the Pfizer vaccine was 88% effective against symptomatic disease from the India variant
Cabinet’s spokesman Nader Saad said Egypt is negotiating with the American Pfizer and the British-Swedish AstraZeneca to obtain batches of coronavirus vaccine.
Margaret Keenan, a 90-year-old grandmother, on Tuesday became the first person in the world to receive the Pfizer COVID-19 vaccine.
Manufacturing is already under way. Pfizer said they expect to supply globally up to 50m vaccine doses in 2020 and up to 1.3bn doses in 2021.
Pharmaceutical giants GlaxoSmithKline and Pfizer on Wednesday announced a merger of their consumer healthcare units that produce over-the-counter medicines.
Reckitt Benckiser has no regrets about its $17 billion acquisition of Mead Johnson last year, its chief executive said.
The U.S. Chamber of Commerce expressed its support for the expansions of the U.S. firms in Egypt.
Sahar Nasr mulled with representatives of two international pharmaceutical companies working in Egypt the injection of $128 million investments within the coming period.